Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

NCT01067469 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Brain Cancer
Glioblastoma

Interventions

DRUG: Standard Dose Bevacizumab
DRUG: Low Dose Bevacizumab
DRUG: Lomustine

Sponsor

M.D. Anderson Cancer Center